US Broker Ratings

Sanofi (SNY) Stock Analysis: A Compelling 30% Upside Potential Amidst Strong Dividend Yield

Sanofi (NASDAQ: SNY), a stalwart in the global healthcare sector, continues to capture investor attention with its robust dividend yield and promising growth potential. With a market capitalization of $102.81..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a Promising 50% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC) has been making waves in the healthcare sector, particularly within the medical devices industry, with its innovative cardiac monitoring solutions. As a digital healthcare company..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech with Promising Upside and Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector, capturing investor attention with its promising pipeline focused on rare neuroendocrine diseases. With a current market capitalization of..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Navigating a 15.35% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX) is capturing investor attention with a compelling upside potential of 15.35%, positioning itself as a promising player in the healthcare sector, specifically within the specialty and..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A 32% Upside Opportunity in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a dynamic player in the biotechnology sector, offers investors a compelling opportunity with a potential upside of 32.39%. Specializing in novel therapeutics for metabolic dysfunction-associated..

Humana Inc. (HUM) Stock Analysis: Evaluating Growth Amidst a Stretched Valuation

Humana Inc. (NYSE: HUM), a stalwart in the healthcare plans industry, boasts a market capitalization of $46.08 billion, marking its prominence within the United States’ healthcare sector. Despite its impressive..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Device Sector with Strategic Growth

Integer Holdings Corporation (NYSE: ITGR) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.19 billion, this Texas-based company..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Powerhouse with a Potential 49.75% Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a trailblazer in the biotechnology sector, is making waves with its innovative RNA interference therapeutics. With a market capitalization of $38.9 billion, the company is..

Qiagen N.V. (QGEN) Stock Analysis: Exploring an 11.55% Potential Upside in the Healthcare Sector

As a key player in the healthcare sector, Qiagen N.V. (NYSE: QGEN) stands out with its robust offerings in the diagnostics and research industry. With a market capitalization of $8.13..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the Diagnostics & Research Sector with a $12.61 Billion Market Cap

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, offers a compelling investment narrative within the diagnostics and research industry. Renowned for its cutting-edge health sciences solutions, Revvity..

Ionis Pharmaceuticals, Inc. (IONS) Investor Outlook: Strong Buy Ratings and 30% Upside Potential

Ionis Pharmaceuticals, Inc. (IONS), a leading player in the biotechnology sector, is offering investors a compelling opportunity with its innovative RNA-targeted medicines. With a market capitalization of $13.42 billion, Ionis..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with 14.59% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) stands as a formidable player in the biotechnology sector, headquartered in London, United Kingdom. With a market capitalization of $24.51 billion, the company has captured..

AptarGroup, Inc. (ATR) Investor Outlook: Exploring a 27% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, has garnered attention from investors seeking stable growth and a promising upside. With a market capitalization of $8.04 billion,..

Globus Medical, Inc. (GMED) Stock Analysis: Uncovering a 25.96% Upside Potential for Investors

Globus Medical, Inc. (NYSE: GMED) stands out in the healthcare sector as a formidable player in the medical devices industry, focusing on innovative solutions for musculoskeletal disorders. With a market..

Teleflex Incorporated (TFX) Stock Analysis: A Closer Look at Its 12.34% Potential Upside

Teleflex Incorporated (NYSE: TFX) is a prominent player in the healthcare sector, specializing in the medical instruments and supplies industry. With a market capitalization of $5.75 billion, this U.S.-based company..

Universal Health Services, Inc. (UHS) Stock Analysis: A 46.77% Upside Potential Beckons Investors

Universal Health Services, Inc. (NYSE: UHS), a stalwart in the healthcare sector, stands at a pivotal intersection for investors seeking opportunities in medical care facilities. With a market capitalization of..

Chemed Corp (CHE) Stock Analysis: Navigating Growth in Healthcare with a Strong ROE of 25.6%

Chemed Corp (NYSE: CHE) stands as a formidable player in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $6.15 billion, this Cincinnati-based company..

BridgeBio Pharma, Inc. (BBIO): Investor Outlook Highlights 45.61% Potential Upside Amid Robust Pipeline

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is capturing the attention of investors with its compelling growth potential in the biotechnology sector. As a key player in healthcare, BridgeBio is making significant..

ResMed Inc. (RMD) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, is catching the eye of investors with its robust market capitalization of $29.05 billion and a compelling potential upside..

Bruker Corporation (BRKR) Stock Analysis: Navigating Challenges with Strategic Innovations

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically within the medical devices industry, has been at the forefront of technological advancements in scientific instruments and analytical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds